Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07429396Not Yet Recruiting

Data-Driven Phenotyping in Heart Failure With Preserved Ejection Fraction

Role: collaborator

NCT07288840Enrolling By Invitation

Exercise Prescription in Cardiac Rehabilitation Mediated by Autonomic Function

Role: collaborator

NCT06919237Not ApplicableNot Yet Recruiting

Effects of Heart Rate Variability-guided Training vs Standard Aerobic Prescription on Cardiovagal Modulation and Cardiorespiratory Fitness in Coronary Artery Disease

Role: collaborator

NCT04786431Completed

Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases

Role: collaborator

All 4 trials loaded